GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Molecular and immunologic evolution of melanomas from pre-neoplastic lesions

$931,980
Boris C Bastian · University Of California, San Francisco · R35 · FY2022 · CA

Next Generation Immunotherapies for Pediatric Cancers

$931,841
Crystal Mackall · Stanford University · R35 · FY2024 · CA

Molecular pathways and targeted therapies in human leukemia

$931,200
Adolfo A. Ferrando · Columbia University Health Sciences · R35 · FY2019 · CA

Molecular heterogeneity of liver cancer and its clinical impacts

$930,599
Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Understanding and Exploiting Loss of Y in Cancer

$930,500
Dan Theodorescu · University Of Arizona · R35 · FY2025 · CA

Role of Tumor Stroma in Therapeutic Response and Resistance

$930,118
Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2011 · CA

Preclinical Mouse Models of Thyroid Cancer

$930,012
Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Targeting breast cancer stem cells

$930,000
Max S. Wicha · University Of Michigan At Ann Arbor · R35 · FY2020 · CA

Targeting breast cancer stem cells

$930,000
Max S. Wicha · University Of Michigan At Ann Arbor · R35 · FY2018 · CA

Human natural killer cells: Advancing biology and clinical applications

$930,000
Michael A Caligiuri · Ohio State University · R35 · FY2017 · CA

Targeting breast cancer stem cells

$930,000
Max S. Wicha · University Of Michigan At Ann Arbor · R35 · FY2017 · CA

Targeting breast cancer stem cells

$930,000
Max S. Wicha · University Of Michigan At Ann Arbor · R35 · FY2016 · CA

Perivascular plasticity in metastatic microenvironments

$929,578
Meera Murgai · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Biophysical and molecular dialogue of glioma cells and the brain microenvironment

$929,349
Gabriele Bergers · University Of California, San Francisco · U54 · FY2015 · CA

Attacking stress tolerance in cancer

$928,703
David A Cheresh · University Of California, San Diego · R35 · FY2022 · CA

First in Human Trials of ProAgio, a Cytotoxin

$928,360
Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Study of CAR T cells and mechanisms of resistance in pediatric brain tumors

$928,184
Anandani Nellan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Regulatory T cells and the tumor microenvironment

$927,924
Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R35 · FY2021 · CA

Dynamics in the Tissue State: From Normal to Tumor and Back

$927,850
Jan T. Liphardt · Stanford University · U54 · FY2013 · CA

Genomic dissection of tumor heterogeneity and progression

$927,446
John Shern · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Overcoming resistance to anti-PD1 immunotherapy

$927,149
Thomas F Gajewski · University Of Chicago · R35 · FY2023 · CA

Preclinical Development of a Novel and Powerful Immunotherapeutic

$926,922
Susan Dana Jones · Immurx Llc · R44 · FY2011 · AI

Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section

$926,839
Jinqiu Chen · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

Sex-based Differences in Glioma

$926,753
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2021 · CA

Therapeutic targets and novel anticancer agents for endocrine cancers

$926,461
Naris Nilubol · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA